roflumilast
arcutis,astrazeneca
['derm', 'roflumilast', 'arcutis', '$arqt']
$arqt new data from arcutis stratum pivotal phase 3 trial of roflumilast foam 0.3% in seborrheic dermatitis presented at european academy of dermatology and venereology (eadv) congress 
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft